These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 884936

  • 21. [Clinical observations on the treatment of ischemic cardiac disease with a calcium antagonist: nifedipine].
    Bufalini AA, Bargero G, Botta M, Marzani MC, Montalenti P, Navazzotti R, Piccolini E, Marzani PC.
    Arch Sci Med (Torino); 1980; 137(4):715-24. PubMed ID: 7247695
    [Abstract] [Full Text] [Related]

  • 22. [Physiopathological aspects of calcium metabolism at the myocardial level. Clinical experience with nifedipine].
    Ripa R, Frisoni B, Farabegoli E, Tisselli R, Tripodi G.
    Boll Soc Ital Cardiol; 1978; 23(6):1079-82. PubMed ID: 261876
    [No Abstract] [Full Text] [Related]

  • 23. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
    Bielawiec M, Lukjan H, Grabowski R, Myśliwiec M, Korfel B.
    Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
    [No Abstract] [Full Text] [Related]

  • 24. [Vasomotor action of acetylcholine o peripheral occlusive arterial diseases (plethysmograpic findings on the leg during acetylcholine arteriosclerosis)].
    Dorigo B, Biti GP.
    Minerva Cardioangiol; 1969 Oct; 17(10):724-9. PubMed ID: 5404965
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R, Pedroni G, Borri P.
    Chir Ital; 1967 Oct; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract] [Full Text] [Related]

  • 27. Peripheral arterial disease: drug therapy.
    Schwartz JB.
    J Gend Specif Med; 2002 Oct; 5(4):16-20. PubMed ID: 12192882
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Calcium antagonists in cardiologic therapy].
    Ripa R.
    Minerva Med; 1978 Oct 13; 69(48):3323-5. PubMed ID: 724143
    [No Abstract] [Full Text] [Related]

  • 32. Diagnosis and treatment of occlusive peripheral arterial disease.
    Spittell JA.
    Geriatrics; 1982 Jan 13; 37(1):57-67. PubMed ID: 7054056
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Beneficial effects of nifedipine on regional myocardial blood flow in patients with coronary artery disease.
    Malacoff RF, Lorell BH, Mudge GH, Holman BL, Idoine J, Bifolck L, Cohn PF.
    Circulation; 1982 Jan 13; 65(1 Pt 2):I32-7. PubMed ID: 7053296
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Vasa Suppl; 1987 Jan 13; 20():384-7. PubMed ID: 3321495
    [No Abstract] [Full Text] [Related]

  • 40. [Effect of papaveroline on chronic, obliterating, peripheral arterial diseases].
    Sironi G, Benedetti G.
    Minerva Cardioangiol; 1973 Apr 13; 21(4):257-63. PubMed ID: 4710122
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.